PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

NEW YORK--()--PAVmed Inc. (NASDAQ:PAVM; PAVMW), a highly differentiated, multi-product medical device company, today announced that Dennis McGrath, PAVmed’s Chief Financial Officer, will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 1:00 p.m. Eastern time. Mr. McGrath will provide a corporate overview, discuss the Company’s innovative business model and review PAVmed’s lead products. The conference will be held at the Wyndham Grand Hotel in Jupiter, Florida on October 18-19, 2017.

To access the live webcast of the presentation, please click here. A replay will be available following the presentation.

About PAVmed Inc.

PAVmed Inc. (Nasdaq: PAVM, PAVMW) is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding multi-product pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs, have attractive regulatory pathways and market opportunities and encompass a broad spectrum of clinical areas including carpal tunnel syndrome (CarpX™), medical infusions (NextFlo™ and NextCath™), interventional radiology (PortIO™ and NextCath), tissue ablation and cardiovascular intervention (Caldus™) and pediatric ear infections (DisappEAR™).

Contacts

Investors
LHA Investor Relations
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
info@pavmed.com
or
Media
RooneyPartners
Thomas Hynes, 212-223-0651
thynes@rooneyco.com

Contacts

Investors
LHA Investor Relations
Kim Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
or
info@pavmed.com
or
Media
RooneyPartners
Thomas Hynes, 212-223-0651
thynes@rooneyco.com